摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 2-(benzamidomethyl)-3-hydroxybutanoate | 903529-16-8

中文名称
——
中文别名
——
英文名称
ethyl 2-(benzamidomethyl)-3-hydroxybutanoate
英文别名
2-benzoylaminomethyl-3-hydroxybutyric acid ethyl ester
ethyl 2-(benzamidomethyl)-3-hydroxybutanoate化学式
CAS
903529-16-8
化学式
C14H19NO4
mdl
——
分子量
265.309
InChiKey
GIRBMFYSMBEDOM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    19
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    75.6
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-(N-苯甲酰胺甲基)-3-酮基丁酸乙酯 在 sodium tetrahydroborate 作用下, 以 乙醇 为溶剂, 生成 ethyl 2-(benzamidomethyl)-3-hydroxybutanoate
    参考文献:
    名称:
    Asymmetric reductions of ethyl 2-(benzamidomethyl)-3-oxobutanoate by yeasts
    摘要:
    The stereoselective reduction of ethyl 2-(benzamidomethyl)-3-oxobutanoate 1 using yeasts was investigated among a restricted number (12) of yeasts. Kluyveromyces marxianus var. lactis CL69 diastereoselectively produced (2R,3S)-ethyl 2-(benzamidomethyl)-3-hydroxybutanoate 2. whereas Pichia glucozyma CBS 5766 gave (2S,3S)-2 as the major stereoisomer. The biotransformations were independently optimized for minimizing by-product formation and maximizing the diastereoselectivity. Under optimized conditions, K. marxianus var. lactis CL 69 gave the (2R,3S)-ethyl 2-(benzamidomethyl)-3-hydroxybutanoate 2 with ee > 99% and de = 98%, while P. glucozyma CBS 5766 allowed for the production of (2S,3S)-2 with ee > 99% and de = 86%. (c) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2009.02.023
点击查看最新优质反应信息

文献信息

  • Dynamic kinetic resolution of β′-keto-β-amino esters using Ru–DTBM–Sunphos catalyzed asymmetric hydrogenation
    作者:Xiaoming Li、Xiaoming Tao、Xin Ma、Wanfang Li、Mengmeng Zhao、Xiaomin Xie、Tahar Ayad、Virginie Ratovelomanana-Vidal、Zhaoguo Zhang
    DOI:10.1016/j.tet.2013.05.136
    日期:2013.8
    higher activity and selectivity than the corresponding [Ru(cymene)I2]2–Sunphos. In situ generated catalyst could be used for this transformation. Asymmetric hydrogenation of a series of β′-keto-β-amino esters derivatives using Ru–Sunphos complexes via dynamic kinetic resolution led to the corresponding β′-hydroxy-β-amino esters with ee up to 99.6% and de up to 98.8% (S/C=1000).
    通过深入研究反应条件,开发了一种方便的对映选择性合成β'-羟基-β-的方法。发现二氯甲烷(DCM)/ 2,2,2-三氟乙醇TFE)和1,2-二氯乙烷(DCE)/ TFE组合是该反应的合适助溶剂。在这种混合溶剂体系中,[Ru(cymene )Cl 2 ] 2 -Sunphos的活性和选择性都比相应的[Ru(cymene)I 2 ] 2高。–Sunphos。原位产生的催化剂可用于该转化。使用Ru-Sunphos配合物通过动态动力学拆分对一系列β'--β-生物进行不对称加,导致相应的β'-羟基-β-的ee高达99.6%,de高达98.8% (S / C= 1000)。
  • METHOD FOR PRODUCING OPTICALLY ACTIVE 2-(N-SUBSTITUTED AMINOMETHYL)-3-HYDROXYBUTYRIC ACID ESTER
    申请人:Yasohara Yoshihiko
    公开号:US20090104671A1
    公开(公告)日:2009-04-23
    The present invention relates to a method for producing optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid esters wherein a 2-(N-substituted aminomethyl)-3-oxobutyric acid ester is treated with an enzyme source capable of stereoselectively reducing said ester to the corresponding optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid ester having the (2S,3R) configuration. The present invention provides an efficient method for industrially producing optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid esters, in particular such compounds having the (2S,3R) configuration, which are useful as intermediates for the production of medicinal compounds, among others.
    本发明涉及一种制备光学活性的2-(N-取代甲基)-3-羟基丁酸的方法,其中将2-(N-取代甲基)-3-氧代丁酸与能够立体选择性还原所述的酶源处理,以得到相应的具有(2S,3R)构型的光学活性的2-(N-取代甲基)-3-羟基丁酸。本发明提供了一种高效的工业制备光学活性的2-(N-取代甲基)-3-羟基丁酸的方法,特别是具有(2S,3R)构型的化合物,这些化合物可用作药物化合物的中间体等。
  • Method for producing optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid ester
    申请人:KANEKA CORPORATION
    公开号:EP2357248A1
    公开(公告)日:2011-08-17
    The present invention relates to a method for producing optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid esters wherein a 2-(N-substituted aminomethyl)-3-oxobutyric acid ester is treated with an enzyme source capable of stereoselectively reducing said ester to the corresponding optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid ester having the (2S,3R) configuration. The present invention provides an efficient method for industrially producing optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid esters, in particular such compounds having the (2S,3R) configuration, which are useful as intermediates for the production of medicinal compounds, among others.
    本发明涉及一种生产光学活性 2-(N-取代甲基)-3-羟基丁酸的方法。 本发明涉及一种生产光学活性 2-(N-取代甲基)-3-羟基丁酸的方法,其中 2-(N-取代甲基)-3-氧代丁酸用一种酶源处理,该酶源能够立体选择性地将所述还原为具有 (2S,3R) 构型的相应光学活性 2-(N-取代甲基)-3-羟基丁酸。本发明提供了一种工业化生产光学活性 2-(N-取代甲基)-3-羟基丁酸的有效方法。 甲基)-3-羟基丁酸,特别是具有 (2S,3R) 构型的此类化合物的有效方法,这些化合物可用作生产药用化合物等的中间体
  • DIOPHEP, a chiral diastereoisomeric bisphosphine ligand: synthesis and applications in asymmetric hydrogenations
    作者:Edoardo Cesarotti、Giorgio Abbiati、Elisabetta Rossi、Paola Spalluto、Isabella Rimoldi
    DOI:10.1016/j.tetasy.2008.07.009
    日期:2008.7
    Novel optically active diphosphine ligands, known as DIOPHEP, have been designed and synthesized starting from a derivative of tartaric acid. The ligands conjugate the sp(3) chirality of the precursor of DIOP with the atropisomeric chirality of a biaryl scaffold. The stereorecognition abilities of DIOPHEP-Ru complex catalysts have been investigated in the asymmetric catalytic hydrogenation of some standard substrates suggesting a close relationship between dihedral angles and enantioselectivity. (C) 2008 Published by Elsevier Ltd.
  • US4927507A
    申请人:——
    公开号:US4927507A
    公开(公告)日:1990-05-22
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸